SARS News and Research

RSS

Post-exposure prophylaxis with monoclonal antibodies may reduce health system burden in the US

In a study conducted at the University of Washington, USA, the researchers assert that post-exposure prophylaxis with monoclonal antibodies could improve the clinical outcomes and health system costs regarding coronavirus disease (COVID-19). The study is currently available on the medRxiv* preprint server.

6 Sep 2021

Study finds SARS-CoV-2 affects the brain by binding with MAO enzymes

A new study by researchers in Croatia and Slovenia shows the SARS-CoV-2 spike protein has an affinity towards monoamine oxidases (MAO) enzymes. Changes in MAO levels have been the culprit for several neuropsychiatric disorders such as Parkinson’s or Alzheimer’s disease.

6 Sep 2021

Using infodemiology to understand symptoms of SARS-CoV-2 Lambda variant

A new variant (lineage C.37) initially identified in Lima, Peru, has since been classified as “Lambda” by the World Health Organization (WHO). The lambda variant was classified in June 2021 by the WHO as a “variant of interest.”

6 Sep 2021

Study finds a restricted number of possible escape mutations for SARS-CoV-2 Delta variant

The emergence of escape mutations in the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is somewhat less likely for the Delta variant in comparison with the original or wild type virus, shows a recent study currently available on the bioRxiv* preprint server while it undergoes peer review.

5 Sep 2021

SARS-CoV-2 epidemic management undermined by relationship between symptoms and secondary transmission

A new study provides evidence of the correlation and estimated the period between the generation interval and incubation period of SARS-CoV-2.

5 Sep 2021

SARS-CoV-2 fusion peptides play distinct roles according to neutron scattering

A new study determines the physical and thermodynamic events associated with the interactions that lead to the fusion between SARS-CoV-2 and the host.

5 Sep 2021

Efficacy of vaccines against the SARS-CoV-2 Delta variant

A new study uses statistical models to determine vaccine efficacy against the various SARS-CoV-2 variants and clinical endpoints for SARS-CoV-2 variants.

5 Sep 2021

Hypopituitarism and COVID-19 – exploring a possible bidirectional relationship?

In a recent study published in Reviews in Endocrine and Metabolic Disorders, the researchers discuss the extra-pulmonary manifestations of COVID-19.

5 Sep 2021

Home blood collection device could be used for measuring antibodies against SARS-CoV-2

A device that could make it possible for patients to draw their own blood at home was successfully used to collect blood samples for measuring antibodies against SARS-CoV-2, the virus that causes COVID-19, researchers at the University of Washington School of Medicine in Seattle report.

4 Sep 2021

New diagnostic system can rapidly and sensitively measure antibodies against SARS-CoV-2

A research team at the RIKEN Center for Emergent Matter Science in Japan has developed a diagnostic system that can rapidly and sensitively measure the amount of antibodies in the blood that can protect us from SARS-CoV-2, the virus that causes COVID-19.

4 Sep 2021

Immunological differences in Moderna and Pfizer-BioNTech vaccine-induced Fc-functional profiles

A new study analyzed the post-boost binding and functional capacity of the humoral response induced by the Pfizer-BioNTech and Moderna vaccines.

3 Sep 2021

Impact of colloidal aggregation in COVID-19 drug repurposing screens

A recent study investigated the influence of colloidal aggregation on early drug development in repurposing screens

3 Sep 2021

Can COVID-19 vaccines affect athletic performance in the short term?

Getting the COVID-19 vaccine — especially the second shot — can produce minor side effects such as aches and fever that tend to go away after a day or two. Adding to the list, a small study from the University of Arizona found that people may find it slightly challenging to exercise after getting a two-dose coronavirus vaccine.

3 Sep 2021

Modeling study shows importance of contact tracing in preventing COVID-19 transmission

In the face of rising vaccination rates, untraced cases may increase the number of COVID-19 cases. A new study led by Choo-Yee Ting from Multimedia University in Malaysia found that contact tracing remains an important tool in mitigating coronavirus spread and subsequent infection.

3 Sep 2021

Smell abnormalities more common among long-COVID Patients

A new study investigates the rising prevalence of abnormalities in the sense of smell persisting in COVID-19 patients.

3 Sep 2021

Third vaccine dose reduces transmission and severe COVID-19 nationwide in Israel

A new preprint investigates the efficacy of a booster vaccine on a nationwide scale in reducing viral spread and the number of severe COVID-19 cases.

3 Sep 2021

Antibody cocktail neutralizes SARS-CoV-2 and has projected protection up to 12 months

A new study reports long-lasting, effective protection against severe disease with the AZD7442 antibody cocktail.

3 Sep 2021

Simple and rapid method measures T-cell immune response to SARS-CoV-2 virus

Researchers from Duke-NUS Medical School, together with collaborators from the National Centre for Infectious Diseases (NCID) and Singapore General Hospital (SGH), have discovered a simple and rapid method to measure the T-cell immune response to the SARS-CoV-2 virus, which causes COVID-19.

3 Sep 2021

Jail decarceration leads to community-wide public health benefits, study shows

How can government slow the spread of COVID-19 in the U.S.? Look to America's unique epidemic engines: jails and prisons in America.

2 Sep 2021

People who received two vaccine doses have lower odds of experiencing long COVID

People who tested positive for SARS-CoV-2 after one or two vaccine doses had significantly lower odds of severe disease or hospitalization than unvaccinated people, according to a large-scale study investigating COVID-19 breakthrough infections published in The Lancet Infectious Diseases journal.

2 Sep 2021

SARS News and Research

Post-exposure prophylaxis with monoclonal antibodies may reduce health system burden in the US

Study finds SARS-CoV-2 affects the brain by binding with MAO enzymes

Using infodemiology to understand symptoms of SARS-CoV-2 Lambda variant

Study finds a restricted number of possible escape mutations for SARS-CoV-2 Delta variant

SARS-CoV-2 epidemic management undermined by relationship between symptoms and secondary transmission

SARS-CoV-2 fusion peptides play distinct roles according to neutron scattering

Efficacy of vaccines against the SARS-CoV-2 Delta variant

Hypopituitarism and COVID-19 – exploring a possible bidirectional relationship?

Home blood collection device could be used for measuring antibodies against SARS-CoV-2

New diagnostic system can rapidly and sensitively measure antibodies against SARS-CoV-2

Immunological differences in Moderna and Pfizer-BioNTech vaccine-induced Fc-functional profiles

Impact of colloidal aggregation in COVID-19 drug repurposing screens

Can COVID-19 vaccines affect athletic performance in the short term?

Modeling study shows importance of contact tracing in preventing COVID-19 transmission

Smell abnormalities more common among long-COVID Patients

Third vaccine dose reduces transmission and severe COVID-19 nationwide in Israel

Antibody cocktail neutralizes SARS-CoV-2 and has projected protection up to 12 months

Simple and rapid method measures T-cell immune response to SARS-CoV-2 virus

Jail decarceration leads to community-wide public health benefits, study shows

People who received two vaccine doses have lower odds of experiencing long COVID

Exploring the G:Box and for high-quality imaging

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Latest News